Diagnostic utility of cytokeratin 19 expression in multinodular goiter with papillary areas and papillary carcinoma of thyroid

Endocrine Pathology

Volumn 13, Issue 3, 2002, Pages 207-211

  Erkiliç, Suna ^a,b   Aydin, Abdullah ^a   Koçer, N Emrah ^a  

^a GAZIANTEP UNIVERSITY   (Turkey)

^b Fevzi Çakmak Bulvari ^*  (Turkey)

Author keywords

Cytokeratin 19; Follicular adenoma; Multinodular goiter; Papillary carcinoma; Thyroid

Indexed keywords

CYTOKERATIN 19;

ADULT; AGED; ARTICLE; BLEEDING; DIAGNOSTIC ACCURACY; DIAGNOSTIC ERROR; DIAGNOSTIC VALUE; DIFFERENTIAL DIAGNOSIS; EVALUATION; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; MALE; NODULAR GOITER; PRIORITY JOURNAL; PROTEIN EXPRESSION; THYROID ADENOMA; THYROID CARCINOMA; THYROID PAPILLARY CARCINOMA;

ADENOCARCINOMA, PAPILLARY; ADOLESCENT; ADULT; AGED; DIAGNOSIS, DIFFERENTIAL; FEMALE; GOITER, NODULAR; HUMANS; IMMUNOHISTOCHEMISTRY; KERATINS; MALE; MIDDLE AGED; PAPILLOMA; TUMOR MARKERS, BIOLOGICAL;

EID: 0036764493     PISSN: 10463976     EISSN: None     Source Type: Journal    
DOI: 10.1385/EP:13:3:207     Document Type: Article

References (13)

1. Raphael SJ, McKeown-Eyssen G, Asa SL. High-molecular-weight cytokeratin and cytokeratin-19 in the diagnosis of thyroid tumors. Mod Pathol 7:295-300, 1994.
2. Schelfout LJ, Van Muijen GN, Fleuren GJ. Expression of keratin 19 distinguishes papillary thyroid carcinoma from follicular carcinomas and follicular thyroid adenoma. Am J Clin Pathol 92:654-658, 1989.
3. Rosai J, Carcangiu ML, DeLellis RA. Tumors of the Thyroid Gland. Atlas of Tumor Pathology, 3rd Series, fascicle 5. Washington, DC: Armed Forces Institute of Pathology, 1992.
4. Chan JKC, Tsang WYW. Endocrine malignancies that may mimic benign lesions. Semin Diagn Pathol 12:45-63, 1995.
5. Miettinen M, Fetsch JF. Distribution of keratins in normal endothelial cells and a spectrum of vascular tumors: Implications in tumor diagnosis. Hum Pathol 31:1062-1067, 2000.
6. Judkins AR, Roberts SA, Livolsi VA. Utility of immunohistochemistry in the evaluation of necrotic thyroid tumors. Hum Pathol 30:1373-1376, 1999.
7. Raphael SJ, Apel RL, Asa SL. Brief report: Detection of high-molecular-weight cytokeratins in neoplastic and non-neoplastic thyroid tumors using microwave antigen retrieval. Mod Pathol 8:870-872, 1995.
8. Bennet WP, Bhan AK, Vickery AL Jr. Keratin expression as a diagnostic adjunct in thyroid tumors with papillary architecture. Lab Invest 58:9, 1988.
9. LiVolsi VA, Merino MJ. Worrisome histologic alterations following fine-needle aspiration of the thyroid (WHAFFT). Pathol Annu 29:99-120, 1994.
10. Sahoo S, Hoda SA, Rosai J, DeLellis RA. Cytokeratin 19 immunoreactivity in the diagnosis of papillary thyroid carcinoma. Am J Clin Pathol 116:696-702, 2000.
11. Baloch ZW, Abraham S, Roberts S, LiVolsi VA. Differential expression of cytokeratins in follicular variant of papillary carcinoma: An immunohistochemical study and its diagnostic utility. Hum Pathol 30:1166-1171, 1999.
12. Miettinen M, Franssila KO. Variable expression of keratins and nearly uniform lack of thyroid transcription factor 1 in thyroid anaplastic carcinoma. Hum Pathol 31 (9): 1139-1144, 2000.
13. Schroder S, Wodzynski A, Padberg B. Cytokeratin expression of benign and malignant epithelial thyroid gland tumors: An immunohistologic study of 154 neoplasms using 8 different monoclonal cytokeratin antibodies. Pathologe 17(6):425-432, 1996.